Determining an effective dose in individual infant eyes is difficult because vitreous VEGF protein produced by the hypoxic retina may vary in separate eyes depending on the zone of ROP--i.e., the extent of avascular retina. Here, VEGFA is linked to retinopathy of prematurity.